The effect of de-escalation of P2Y12 receptor inhibitor therapy after acute myocardial infarction in patients undergoing percutaneous coronary intervention: A nationwide cohort study.
To examine the effect of de-escalation of P2Y12 inhibitor in dual antiplatelet therapy (DAPT) on major adverse cardiovascular events (MACE) and bleeding complications after acute myocardial infarction (AMI) in Taiwanese patients undergoing percutaneous coronary intervention (PCI). Patients who had r...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0246029 |
id |
doaj-069fea88540a4a058d3f22323f9c1c52 |
---|---|
record_format |
Article |
spelling |
doaj-069fea88540a4a058d3f22323f9c1c522021-06-27T04:30:44ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01161e024602910.1371/journal.pone.0246029The effect of de-escalation of P2Y12 receptor inhibitor therapy after acute myocardial infarction in patients undergoing percutaneous coronary intervention: A nationwide cohort study.Jong-Shiuan YehChien-Yi HsuChun-Yao HuangWan-Ting ChenYi-Chen HsiehLi-Nien ChienTo examine the effect of de-escalation of P2Y12 inhibitor in dual antiplatelet therapy (DAPT) on major adverse cardiovascular events (MACE) and bleeding complications after acute myocardial infarction (AMI) in Taiwanese patients undergoing percutaneous coronary intervention (PCI). Patients who had received PCI during hospitalization for AMI (between 2013 and 2016) and were initially treated with aspirin and ticagrelor and without adverse events after 3 months of treatment were retrospectively evaluated. In total, 1,901 and 8,199 patients were identified as "de-escalated DAPT" (switched to aspirin and clopidogrel) and "unchanged DAPT" (continued on aspirin and ticagrelor) cohorts, respectively. With a mean follow-up of 8 months, the incidence rates (per 100 person-year) of death, AMI readmission and MACE were 2.89, 3.68, and 4.91 in the de-escalated cohort and 2.42, 3.28, and 4.72 in the unchanged cohort, respectively, based on an inverse probability of treatment weighted approach that adjusting for baseline characteristics of the patients. Multivariate Cox regression analyses showed the two groups had no significant differences in the hazard risk of death, AMI admission, and MACE. Additionally, there was no observed difference in the risk of bleeding, including major or clinically relevant non-major bleeding. The real-world data revealed that de-escalation of P2Y12 inhibitor in DAPT was not associated with a higher risk of death or AMI readmission in Taiwanese patients with AMI undergoing successful PCI.https://doi.org/10.1371/journal.pone.0246029 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jong-Shiuan Yeh Chien-Yi Hsu Chun-Yao Huang Wan-Ting Chen Yi-Chen Hsieh Li-Nien Chien |
spellingShingle |
Jong-Shiuan Yeh Chien-Yi Hsu Chun-Yao Huang Wan-Ting Chen Yi-Chen Hsieh Li-Nien Chien The effect of de-escalation of P2Y12 receptor inhibitor therapy after acute myocardial infarction in patients undergoing percutaneous coronary intervention: A nationwide cohort study. PLoS ONE |
author_facet |
Jong-Shiuan Yeh Chien-Yi Hsu Chun-Yao Huang Wan-Ting Chen Yi-Chen Hsieh Li-Nien Chien |
author_sort |
Jong-Shiuan Yeh |
title |
The effect of de-escalation of P2Y12 receptor inhibitor therapy after acute myocardial infarction in patients undergoing percutaneous coronary intervention: A nationwide cohort study. |
title_short |
The effect of de-escalation of P2Y12 receptor inhibitor therapy after acute myocardial infarction in patients undergoing percutaneous coronary intervention: A nationwide cohort study. |
title_full |
The effect of de-escalation of P2Y12 receptor inhibitor therapy after acute myocardial infarction in patients undergoing percutaneous coronary intervention: A nationwide cohort study. |
title_fullStr |
The effect of de-escalation of P2Y12 receptor inhibitor therapy after acute myocardial infarction in patients undergoing percutaneous coronary intervention: A nationwide cohort study. |
title_full_unstemmed |
The effect of de-escalation of P2Y12 receptor inhibitor therapy after acute myocardial infarction in patients undergoing percutaneous coronary intervention: A nationwide cohort study. |
title_sort |
effect of de-escalation of p2y12 receptor inhibitor therapy after acute myocardial infarction in patients undergoing percutaneous coronary intervention: a nationwide cohort study. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2021-01-01 |
description |
To examine the effect of de-escalation of P2Y12 inhibitor in dual antiplatelet therapy (DAPT) on major adverse cardiovascular events (MACE) and bleeding complications after acute myocardial infarction (AMI) in Taiwanese patients undergoing percutaneous coronary intervention (PCI). Patients who had received PCI during hospitalization for AMI (between 2013 and 2016) and were initially treated with aspirin and ticagrelor and without adverse events after 3 months of treatment were retrospectively evaluated. In total, 1,901 and 8,199 patients were identified as "de-escalated DAPT" (switched to aspirin and clopidogrel) and "unchanged DAPT" (continued on aspirin and ticagrelor) cohorts, respectively. With a mean follow-up of 8 months, the incidence rates (per 100 person-year) of death, AMI readmission and MACE were 2.89, 3.68, and 4.91 in the de-escalated cohort and 2.42, 3.28, and 4.72 in the unchanged cohort, respectively, based on an inverse probability of treatment weighted approach that adjusting for baseline characteristics of the patients. Multivariate Cox regression analyses showed the two groups had no significant differences in the hazard risk of death, AMI admission, and MACE. Additionally, there was no observed difference in the risk of bleeding, including major or clinically relevant non-major bleeding. The real-world data revealed that de-escalation of P2Y12 inhibitor in DAPT was not associated with a higher risk of death or AMI readmission in Taiwanese patients with AMI undergoing successful PCI. |
url |
https://doi.org/10.1371/journal.pone.0246029 |
work_keys_str_mv |
AT jongshiuanyeh theeffectofdeescalationofp2y12receptorinhibitortherapyafteracutemyocardialinfarctioninpatientsundergoingpercutaneouscoronaryinterventionanationwidecohortstudy AT chienyihsu theeffectofdeescalationofp2y12receptorinhibitortherapyafteracutemyocardialinfarctioninpatientsundergoingpercutaneouscoronaryinterventionanationwidecohortstudy AT chunyaohuang theeffectofdeescalationofp2y12receptorinhibitortherapyafteracutemyocardialinfarctioninpatientsundergoingpercutaneouscoronaryinterventionanationwidecohortstudy AT wantingchen theeffectofdeescalationofp2y12receptorinhibitortherapyafteracutemyocardialinfarctioninpatientsundergoingpercutaneouscoronaryinterventionanationwidecohortstudy AT yichenhsieh theeffectofdeescalationofp2y12receptorinhibitortherapyafteracutemyocardialinfarctioninpatientsundergoingpercutaneouscoronaryinterventionanationwidecohortstudy AT linienchien theeffectofdeescalationofp2y12receptorinhibitortherapyafteracutemyocardialinfarctioninpatientsundergoingpercutaneouscoronaryinterventionanationwidecohortstudy AT jongshiuanyeh effectofdeescalationofp2y12receptorinhibitortherapyafteracutemyocardialinfarctioninpatientsundergoingpercutaneouscoronaryinterventionanationwidecohortstudy AT chienyihsu effectofdeescalationofp2y12receptorinhibitortherapyafteracutemyocardialinfarctioninpatientsundergoingpercutaneouscoronaryinterventionanationwidecohortstudy AT chunyaohuang effectofdeescalationofp2y12receptorinhibitortherapyafteracutemyocardialinfarctioninpatientsundergoingpercutaneouscoronaryinterventionanationwidecohortstudy AT wantingchen effectofdeescalationofp2y12receptorinhibitortherapyafteracutemyocardialinfarctioninpatientsundergoingpercutaneouscoronaryinterventionanationwidecohortstudy AT yichenhsieh effectofdeescalationofp2y12receptorinhibitortherapyafteracutemyocardialinfarctioninpatientsundergoingpercutaneouscoronaryinterventionanationwidecohortstudy AT linienchien effectofdeescalationofp2y12receptorinhibitortherapyafteracutemyocardialinfarctioninpatientsundergoingpercutaneouscoronaryinterventionanationwidecohortstudy |
_version_ |
1721358587455864832 |